Patents Examined by Elizabeth C. Weimar
  • Patent number: 5073676
    Abstract: Recombinant DNA comprises promoter and terminator base sequences respectively upstream and downstream of an inverted base sequence complementary to a substantial sequence of bases in polygalacturonase mRNA. The antisense mRNA produced thereby delays softening of fruit, in particular tomatoes.
    Type: Grant
    Filed: September 29, 1989
    Date of Patent: December 17, 1991
    Assignee: Imperial Chemical Industries PLC
    Inventors: Ian G. Bridges, Wolfgang W. Schuch, Donald Grierson
  • Patent number: 5070018
    Abstract: A method of controlling expression of a DNA segment under the control of a nod gene promoter which comprises administering to a host containing a nod gene promoter an amount sufficient to control expression of the DNA segment of a compound of the formula: ##STR1## in which each R is independently H or OH, is described.
    Type: Grant
    Filed: November 7, 1986
    Date of Patent: December 3, 1991
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Norman K. Peters, John W. Frost, Sharon R. Long
  • Patent number: 5068184
    Abstract: A vanilla flavor composition produced by vanilla-plant callus cells suspended in tissue culture, under conditions which promote secretion of vanilla flavor components into the culture medium. The flavor components may be separated from the medium by adsorption resins. Also disclosed are methods for preparing callus cells capable of secreting flavor components in tissue culture, and callus cells produced thereby.
    Type: Grant
    Filed: July 22, 1988
    Date of Patent: November 26, 1991
    Assignee: Escagenetics, Inc.
    Inventors: Mark E. Knuth, Om P. Sahai
  • Patent number: 5066594
    Abstract: The present method is directed to a method for the in vitro stabilization and manipulation of pollen from flowering plants. Specifically, the in vitro stabilization method comprises stabilizing germinating pollen in an aqueous stabilizing solution. The growth of the pollen tube may be resumed by suspending the stabilized pollen in germination medium. Stabilized pollens may be used as vectors for the transfer of exogenous DNA into plants or in gametophyte selection.
    Type: Grant
    Filed: May 9, 1989
    Date of Patent: November 19, 1991
    Assignee: DNA Plant Technology
    Inventors: Lorin R. DeBonte, Willie H. T. Loh
  • Patent number: 5066595
    Abstract: The present invention is directed to a process for increasing the free pool lysine content of individual maize seeds and for increasing the average free pool lysine content of seeds produced by a maize plant. The process, in general, comprises initiating callus from maize tissue, selecting for callus tissue resistant to S-2-aminoethyl-L-cysteine, and regenerating plants from the selected callus. In addition, the callus may be maintained before or during the selection scheme, or in place of the selection scheme.
    Type: Grant
    Filed: November 7, 1989
    Date of Patent: November 19, 1991
    Assignee: Sungene Technologies Corporation
    Inventors: Ernest T. Hubbard, Michele D. Hollingsworth, N. V. Raghava Ram, Judith P. Cook
  • Patent number: 5063158
    Abstract: The present invention is composed of novel recombinant DNA expression vectors which contain a transcriptional activating sequence, a translational activating sequence and a DNA sequence coding for a functional polypeptide, especially bovine growth hormone. The aforementioned translational activating sequences contain a ribosome binding site and are designed to provide high level expression of DNA that codes for virtually any functional polypeptide. The invention further provides transformed microbial host cells capable of producing bovine growth hormone and other functional polypeptides at high levels.
    Type: Grant
    Filed: December 12, 1989
    Date of Patent: November 5, 1991
    Assignee: Eli Lilly and Company
    Inventors: Brigitte E. Schoner, Ronald G. Schoner
  • Patent number: 5063157
    Abstract: The present invention provides a serum-free culture medium for mammalian cells, especially non-adherent cells, containing a base medium, transferrin, insulin and selenite, wherein it contains or consists of2 to 10 mg./liter transferrin,2 to 10 mg./liter insulin,1 to 10 g./liter peptone,10 to 500 mg./liter beta-D-xylopyranose substituted with phosphate, carboxyl and/or sulphate groups,0.1 to 0.5 mg./liter selenite and0.1 to 2 mg./liter biological polyamine.
    Type: Grant
    Filed: January 11, 1989
    Date of Patent: November 5, 1991
    Assignee: Boehringer Mannheim GmbH
    Inventor: Hubertus Stockinger
  • Patent number: 5063160
    Abstract: A novel lipase from a newly-discovered strain of Pseudomonas alcaligenes microorganism having (i) an optimum pH for activity of about 10.+-.0.5; (ii) an optimum temperature for activity of about 45.degree. to 55.degree. C.; (iii) an optimum pH for stability of about 7.0.+-.0.5; (iv) a molecular weight as measured by gel permeation chromotagraphy of about 8.8.times.10.sup.4 ; and (v) chemical stability for at least 30 days in the presence of the surfactants. Also claimed is a biologically pure culture of the microorganism, and a method for the production of the lipase.
    Type: Grant
    Filed: March 16, 1989
    Date of Patent: November 5, 1991
    Assignee: Olin Corporation
    Inventor: Paul E. Holmes
  • Patent number: 5061629
    Abstract: Enantiomerically pure (2R)-2-hydroxy arylalkanoic acid esters and (2S)-2-hydroxy arylalkanoic acids are prepared by the Pseudomonas lipase-catalyzed selective hydrolyxis of racemic (2RS)-2-hydroxy arylalkanoic acid esters in solution or suspension in an aqueous medium at a controlled pH of from about 5 to about 9.
    Type: Grant
    Filed: October 29, 1990
    Date of Patent: October 29, 1991
    Assignee: Hoffman-La Roche Inc.
    Inventors: David L. Coffen, Panayiotis Kalaritis, John J. Patridge
  • Patent number: 5061625
    Abstract: To prepare a microorganism producing .alpha.-galactosidase, not only a DNA containing an .alpha.-galactosidase gene but also a vector which is appropriate to the transformable cells to be used and contains antibiotic resistance genes are completely split with restriction endonuclease Sal I, the fragment of approximately four megadaltons of relative molecular weight is obtained from the fragments of the DNA containing the .alpha.-galactosidase gene, is mixed with the solution of the vector also split with Sal I, and is recombined in the presence of DNA ligase with the formation of a recombinant DNA.
    Type: Grant
    Filed: August 24, 1988
    Date of Patent: October 29, 1991
    Assignee: Boehringer Mannheim GmbH
    Inventors: Ralf Mattes, Klaus Beaucamp
  • Patent number: 5061628
    Abstract: A novel Type II restriction endonuclease isolated from Frankia species DDB13250120 is provided. The enzyme, designated FseI, recognizes the octanucleotide sequence ##STR1## and cleaves Adenovirus 2 DNA at the sites indicated by the arrows.
    Type: Grant
    Filed: July 18, 1989
    Date of Patent: October 29, 1991
    Assignees: Rutgers University, Cold Spring Harbor Laboratory
    Inventors: Richard J. Roberts, Janise L. Meyertons, Mary P. Lechevalier
  • Patent number: 5061620
    Abstract: Human hematopoietic stem cells are provided by separation of the stem cells from dedicated cells. The stem cells may than be maintained by regeneration in an appropriate growth medium. Means are provided for assaying for the stem cells as to their capability for producing members of each of the hematopoietic lineages.
    Type: Grant
    Filed: March 30, 1990
    Date of Patent: October 29, 1991
    Assignee: SyStemix, Inc.
    Inventors: Ann Tsukamoto, Charles M. Baum, Yukoh Aihara, Irving Weissman
  • Patent number: 5061490
    Abstract: A biological inoculant is disclosed for facilitating and fostering the growth of edible corn plants. The inoculant includes biologically pure cultures of bacterial strains, including Bacillus circulans, a yet unidentified bacterial strain, and Xanthomonas maltotphilia.
    Type: Grant
    Filed: May 5, 1990
    Date of Patent: October 29, 1991
    Assignee: W. R. Grace & Co.-Conn.
    Inventors: Alan S. Paau, Dennis E. McCabe, Steven G. Platt
  • Patent number: 5059533
    Abstract: Rhizobial ferredoxin genes and proteins are provided. Rhizobial ferredoxins are useful to enhance the nitrogenase systems of rhizobia. Useful rhizobial ferredoxin diagnostic segments are also provided comprising DNA sequences encoding the characteristic ferredoxin cysteine residue patterns. Exemplied rhizobial ferredoxin genes are fixX of Rhizobium trifolii and Rhizobium meliloti Between fixC and nifA, fixY of Rhizobium meliloti down stream from nifB, and frxA of Bradyrhizobium japonicum.
    Type: Grant
    Filed: July 15, 1988
    Date of Patent: October 22, 1991
    Assignee: Lubrizol Genetics, Inc.
    Inventors: John M. Watson, Siiri E. Iismaa, Helmut Reilander, Alfred Puhler, Hauke Hennecke
  • Patent number: 5059745
    Abstract: A novel inbred corn line, designated LH195, is disclosed. The invention relates to the seeds of inbred corn line LH195, to the plants of inbred corn line LH195 and to methods for producing a corn plant produced by crossing the inbred line LH195 with itself or another corn line. The invention further relates to hybrid corn seeds and plants produced by crossing the inbred line LH195 with another corn line.
    Type: Grant
    Filed: December 4, 1989
    Date of Patent: October 22, 1991
    Assignee: Holden's Foundation Seeds, Inc.
    Inventor: Terry J. Foley
  • Patent number: 5059534
    Abstract: The isolation and characterization of nodD-related genes in soybean nodulating Rhizobium japonicum is described. In R. japonicum USDA 191 two such genes have been identified, which although related in structure, have different functional properties. These nodD genes are functionally distinct from each other and from those nodD genes of other strains of Rhizobium that have been isolated and characterized to date. In particular, nodD-r1 has been found to affect nodulation on soybean and to be associated with exopolysaccharide production. In contrast, nodD-r2 affects nodulation on the tropical legume siratro. The coding sequences of both nodD genes are provided. The promoter regions of the nodD genes have also been isolated. The genes described herein, including both structural genes and their promoter regions, can be used in combination with other genetic constructs to enhance the efficiency and competitiveness of nodulation.
    Type: Grant
    Filed: July 17, 1989
    Date of Patent: October 22, 1991
    Assignee: Lubrizol Genetics, Inc.
    Inventor: Edward R. Appelbaum
  • Patent number: 5057417
    Abstract: Growth hormone receptor and growth hormone binding protein are purified enabling amino acid sequence and DNA isolates coding for growth hormone receptor and growth hormone binding protein and methods of obtaining such DNA are provided, together with expression systems for recombinant production of growth hormone receptor and growth hormone binding protein. Therapeutically useful forms of the growth hormone receptor and growth hormone binding protein and anti-receptor antibodies are described.
    Type: Grant
    Filed: June 12, 1987
    Date of Patent: October 15, 1991
    Assignee: Genentech, Inc.
    Inventors: R. Glenn Hammonds, David W. Leung, Steven A. Spencer, William I. Wood
  • Patent number: 5057420
    Abstract: A process to produce viable bovine embryos through nuclear transplantation. The process utilizes nuclear material from 4 cell and later stage developed embryos recovered from inseminated donor cows through nonsurgical or surgical means. Recipient eggs or oocytes are recovered and a portion of the ooplasm removed by micromanipulation. Individually separated cells from the nuclear material donor embryo are inserted into the recipient oocyte. The oocyte fragment and nuclear donor material are electrofused. The embryo is cultured in vitro, transferred for an interim time to a sheep oviduct and then transferred to a cow for gestation.
    Type: Grant
    Filed: October 16, 1990
    Date of Patent: October 15, 1991
    Assignee: Granada Biosciences, Inc.
    Inventor: Joseph M. Massey
  • Patent number: 5057422
    Abstract: This invention relates to recombinant DNA comprising vector-DNA and a DNA sequence corresponding with, or relates to, a salicylate-inducible promoter of a GRP gene of plants, such as tobacco plants. The invention also relates to microorganisms, plant cells and plants transformed using the recombinant DNA, to a process for introducing an inducible property in plants and to a process for producing a polypeptide or protein, using plant cells and plants transformed using the recombinant DNA.
    Type: Grant
    Filed: March 22, 1989
    Date of Patent: October 15, 1991
    Assignees: Mogen International N.V., Rijksuniversiteit Leiden
    Inventors: John F. Bol, Bernardus J. C. Cornelissen, Johannes A. L. van Kan
  • Patent number: 5057423
    Abstract: A method for the preparation of LAK-active lymphocytes; a method of immunotherapy utilizing these LAK-active lymphocytes, relatively homogeneous compositions of large granular lymphocytes, and relatively homogeneous compositions of LAK-active lymphocytes.
    Type: Grant
    Filed: December 18, 1987
    Date of Patent: October 15, 1991
    Assignee: University of Pittsburgh
    Inventors: John C. Hiserodt, Nikola L. Vujanovic